Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 516408, 5 pages
http://dx.doi.org/10.1100/2012/516408
Research Article

Antileishmanial Activity of Warifteine: A Bisbenzylisoquinoline Alkaloid Isolated from Cissampelos sympodialis Eichl. (Menispermaceae)

1Departamento de Histologia e Embriologia, Centro de Ciências Biológicas, Universidade Federal de Pernambuco, Avenida Professor Moraes Rego 1265, Cidade Universitária, 50670-901 Recife, PE, Brazil
2Departamento de Microbiologia, Centro de Pesquisas Aggeu Magalhães/FIOCRUZ, 50670-420 Recife, PE, Brazil
3Laboratório de Tecnologia Farmacêutica, Universidade Federal da Paraíba, Campus I, 58051-900 João Pessoa, PB, Brazil
4Departamento de Antibióticos, Centro de Ciências Biológicas, Universidade Federal de Pernambuco, Avenida Professor Moraes Rego, 1265, Cidade Universitária, 50670-901 Recife, PE, Brazil
5Departamento de Ensino de Enfermagem, Universidade Salgado de Oliveira, 51170-000 Recife, PE, Brazil
6Departamento de Genética, Centro de Ciências Biológicas, Universidade Federal de Pernambuco, Avenida Professor Moraes Rego 1265, Cidade Universitária, 50670-901 Recife, PE, Brazil

Received 22 May 2012; Accepted 25 July 2012

Academic Editors: J. P. Ackers, G. Cancrini, and J.-T. Cheng

Copyright © 2012 Eliete Cavalcanti da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Technical Report Series: control of leishmaniases,” in WHO. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, WHO, Geneva, Switzerland, 2010, http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf. View at Google Scholar
  2. E. M. Moore and D. N. Lockwood, “Treatment of visceral leishmaniasis,” Journal of Global Infectious Diseases, vol. 2, no. 2, pp. 151–158, 2010. View at Google Scholar
  3. J. Chakravarty and S. Sundar, “Drug resistance in leishmaniasis,” Journal of Global Infectious Diseases, vol. 2, no. 2, pp. 167–176, 2010. View at Google Scholar
  4. F. S. De Cortes, J. L. De Alencar, G. Thomas, and J. M. Barbosa Filho, “Spasmolytic actions of warifteine, a bisbenzylisoquinoline alkaloid isolated from the root bark of Cissampelos sympodialis Eichl. (Menispermaceae),” Phytotherapy Research, vol. 9, no. 8, pp. 579–583, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Fournet, A. A. Barrios, V. Munoz, R. Hocquemiller, and A. Cave, “Effect of some bisbenzylisoquinoline alkaloids on American Leishmania sp. in BALB/c mice,” Phytotherapy Research, vol. 7, no. 4, pp. 281–284, 1993. View at Google Scholar · View at Scopus
  6. A. R. De Arias, A. Inchausti, M. Ascurrat, N. Fleitas, E. Rodriguez, and A. Fournet, “In vitro activity and mutagenicity of bisbenzylisoquinolines and quinones against Trypanosoma cruzi trypomastigotes,” Phytotherapy Research, vol. 8, no. 3, pp. 141–144, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. C. K. Angerhofer, H. Guinaudeau, V. Wongpanich, J. M. Pezzuto, and G. A. Cordell, “Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids,” Journal of Natural Products, vol. 62, no. 1, pp. 59–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. C. W. Wright, S. J. Marshall, P. F. Russell et al., “In vitro antiplasmodial, antiamoebic, and cytotoxic activities of some monomeric isoquinoline alkaloids,” Journal of Natural Products, vol. 63, no. 12, pp. 1638–1640, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Fournet, A. Rojas De Arias, M. E. Ferreira et al., “Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model,” International Journal of Antimicrobial Agents, vol. 13, no. 3, pp. 189–195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Otshudi, S. Apers, L. Pieters et al., “Biologically active bisbenzylisoquinoline alkaloids from the root bark of Epinetrum villosum,” Journal of Ethnopharmacology, vol. 102, no. 1, pp. 89–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. De Freitas, S. F. De Cortes, G. Thomas, and J. M. Barbosa Filho, “Modification of Ca2+ metabolism in the rabbit aorta as a mechanism of spasmolytic action of warifteine, a bisbenzylisoquinoline alkaloid isolated from the leaves of Cissampelos sympodialis Eichl. (Menispermaceae),” Journal of Pharmacy and Pharmacology, vol. 48, no. 3, pp. 332–336, 1996. View at Google Scholar · View at Scopus
  12. H. F. Costa, C. R. Bezerra-Santos, J. M. Barbosa Filho, M. A. Martins, and M. R. Piuvezam, “Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals,” International Immunopharmacology, vol. 8, no. 4, pp. 519–525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Lambson, A. Smyth, and D. Barker, “Sequence homology within a minicircle class of the Leishmania donovani complex,” Molecular and Biochemical Parasitology, vol. 101, no. 1-2, pp. 229–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Google Scholar · View at Scopus
  15. R. A. N. Santos, Efeito do extrato de folhas de Cissampelos sympodialis e do alcalóidewarifteína em modelos experimentais de leishmaniose cutânea [Ph.D. thesis], Universidade Federal da Paraíba, João Pessoa, Brazil, 2001, http://capesdw.capes.gov.br/capesdw/resumo.html?idtese=20015024001015015P5.
  16. A. F. Marinho, J. M. Barbosa-Filho, and E. J. Oliveira, “A validadet method for the simulataneous quantitation of bioactive alkaloid markes in the leaf ethanolic extract of Cissampelos sympodialis Eichl.: a phonological variation study,” Phytochemical Analysis, vol. 23, no. 5, pp. 426–432, 2012. View at Google Scholar
  17. K. Aït-Oudhia, E. Gazanion, D. Sereno et al., “In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure,” Veterinary Parasitology, vol. 187, no. 3-4, pp. 386–393, 2012. View at Google Scholar
  18. A. G. Tempone, N. N. Taniwaki, and J. Q. Reimão, “Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine,” Parasitology Research, vol. 105, no. 2, pp. 499–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Lemesre, D. Sereno, S. Daulouède, B. Veyret, N. Brajon, and P. Vincendeau, “Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms,” Experimental Parasitology, vol. 86, no. 1, pp. 58–68, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. P. S. Melo, H. M. De Medeiros Cavalcante, J. M. Barbosa-Filho, M. De Fátima Formiga Melo Diniz, I. A. De Medeiros, and M. Haun, “Warifteine and milonine, alkaloids isolated from Cissampelos sympodialis Eichl: cytotoxicity on rat hepatocyte culture and in V79 cells,” Toxicology Letters, vol. 142, no. 1-2, pp. 143–151, 2003. View at Publisher · View at Google Scholar · View at Scopus